U.S. Physical Therapy (USPH) is a Healthcare company in the Medical Care Facilities industry. It has a market capitalization of $1.48B, a trailing price-to-earnings ratio of 37.1 and a free-cash-flow yield of 4.0%. Over the most recent reported fiscal year, revenue grew 16.3% and free cash flow per share fell 7.9%. Nama's AI scorecard rates it Sell, 4.1 out of 10. On 12-month momentum it ranks in the middle band of its market.
AI scorecard
Sell · 4.1/10
Negative, at the mild end of Sell. As of Nov 7, 2026.
Momentum
Middle · +7.0% over 12 months ex. last
Middle fifth of its market on the past year's move.
Shariah screen
Not Shariah Compliant
At least one of the three ratios or the industry test failed.
Off its high
-24.3%
How far the last close sits under the highest price of the past five years.
Market cap
$1.48B
Trailing P/E
37.1
Price / book
3.3
Price / sales
1.9
FCF yield
4.0%
Dividend yield
1.9%
Gross margin
18.7%
Operating margin
9.7%
Net margin
-1.0%
Revenue growth (YoY)
+16.3%
Revenue growth (3-yr annual)
+12.2%
EPS growth (YoY)
+7.4%
FCF/share growth (YoY)
-7.9%
Beta
1.1
Exchange
NYSE
Sector
Healthcare
Industry
Medical Care Facilities
USPH earnings
Next report: Feb 24, 2027 (Q4 2026, EPS estimate $0.99).
Beat the EPS estimate in 1 of 4 recent quarters.
Quarter
Reported
EPS
Estimate
Surprise
Revenue
Q3 2026
Nov 4, 2026
$0.80
$0.73
+9.6%
—
Q2 2026
Aug 5, 2026
$0.75
$0.84
-10.7%
$214.06M
Q1 2026
May 6, 2026
$0.46
$0.52
-11.5%
$198.29M
Q4 2025
Feb 26, 2026
$0.67
$0.67
+0.0%
$202.73M
USPH analyst price target
Median target $98.00 from 6 analysts, ranging $95.00 – $101.00.
Nama's AI scorecard currently rates U.S. Physical Therapy Sell (4.1 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is USPH's P/E ratio?
U.S. Physical Therapy trades at a trailing price-to-earnings ratio of 37.1.
When does USPH report earnings?
U.S. Physical Therapy's next scheduled report is on Feb 24, 2027. Analysts expect EPS of $0.99.
What is the USPH price target?
The median analyst price target from 6 analysts is $98.00, with a range of $95.00 – $101.00.
Is USPH Shariah compliant?
Nama's AAOIFI-style screen reads U.S. Physical Therapy as Not Shariah Compliant. At least one of the three ratios or the industry test failed.
Does USPH pay a dividend?
Yes — U.S. Physical Therapy's dividend yield is 1.9%.